Carotenoids and carotenoid conversion products in adipose tissue biology and obesity: Pre-clinical and human studies

https://doi.org/10.1016/j.bbalip.2020.158676Get rights and content

Highlights

  • Adipose tissues (ATs) are key targets of carotenoids and conversion products (CCPs).

  • Carotenoids and CCPs trigger antiadiposity activity though multiple mechanisms.

  • New functions of CCPs in the early life programming of ATs features are emerging.

  • Observational studies sustain a relationship of carotenoids and CCPs with human obesity.

  • Genetic variants might influence carotenoid and CCP metabolism in ATs in humans.

Abstract

Antiobesity activities of carotenoids and carotenoid conversion products (CCPs) have been demonstrated in pre-clinical studies, and mechanisms behind have begun to be unveiled, thus suggesting these compounds may help obesity prevention and management. The antiobesity action of carotenoids and CCPs can be traced to effects in multiple tissues, notably the adipose tissues. Key aspects of the biology of adipose tissues appear to be affected by carotenoid and CCPs, including adipogenesis, metabolic capacities for energy storage, release and inefficient oxidation, secretory function, and modulation of oxidative stress and inflammatory pathways. Here, we review the connections of carotenoids and CCPs with adipose tissue biology and obesity as revealed by cell and animal intervention studies, studies addressing the role of endogenous retinoid metabolism, and human epidemiological and intervention studies. We also consider human genetic variability influencing carotenoid and vitamin A metabolism, particularly in adipose tissues, as a potentially relevant aspect towards personalization of dietary recommendations to prevent or manage obesity and optimize metabolic health. This article is part of a Special Issue entitled Carotenoids recent advances in cell and molecular biology edited by Johannes von Lintig and Loredana Quadro.

Introduction

Excessive body fat accumulation is a defining feature of overweight and obesity [1]. These conditions - especially when excess fat is in the visceral area or in ectopic (non-adipose tissue) locations - are associated to health risk factors such as insulin resistance, dyslipidemia, or hypertension that could lead to suffering of metabolic syndrome. The worldwide prevalence of overweight and obesity has doubled since 1980 [2]. Reversal of obesity is difficult once established. The current obesity pandemic, and the recognition that traditional strategies based solely on food restriction and increased physical activity are being ineffective against it, is boosting research in coadjuvant treatments that could effectively complement life-style modifications. In recent years, antiobesity activities of carotenoids and carotenoid derived products have been demonstrated in a number of pre-clinical studies, and molecular mechanisms behind have begun to be unveiled, suggesting these compounds may help obesity prevention and management. Furthermore, there is increasing evidence that endogenous carotenoid and retinoid metabolism may modulate physiological processes connected to body fat regulation.

Carotenoids are isoprenoid pigments in the yellow to red range, synthetized by plants and microorganisms, which contain in their molecule a polyene backbone with a variable number of conjugated double bounds. Carotenoids can be cyclic or acyclic, depending on the presence or absence of end rings in their structure, and can contain exclusively carbon and hydrogen atoms (carotenes) or contain as well oxygen atoms (xanthophylls) [3]. The double bond system confers on carotenoids antioxidant properties and the capability to absorb light in the visible spectrum. Photosynthetic organisms utilize carotenoids for light harvesting, as photoprotectants, and as precursors of signaling molecules [3]. Carotenoids are eaten by animals mainly through fruits and vegetables, and - at least some of them - serve functions in animals, either as intact molecules or following metabolism. Metabolism of carotenoids usually involves the oxidative cleavage - enzymatic or nonenzymatic - of the polyene backbone, at central or eccentric positions, which gives rise to shortened derivatives known as apocarotenoids. It can also involve other reactions, such as modifications of terminal groups. Of the hundreds of carotenoids in nature, ~50 are present in the human diet, and six are ubiquitously found in human serum: β-carotene, α-carotene, β-cryptoxanthin, lycopene, lutein, and zeaxanthin [3]. The colorless carotenoids phytoene and phytofluene are also major carotenoids consistently detected in human plasma and tissues [4].

In mammals, the best known function of carotenoids is to serve as precursors of the natural vitamin A retinoids: retinol, retinaldehyde, and retinoic acid. Provitamin A activity is restricted to carotenoids with at least one unsubstituted β ionone ring, such as β-carotene (considered the most potent vitamin A precursor, since it is the only carotenoid with two unsubstituted β ionone rings), α-carotene, and β-cryptoxanthin. These carotenoids are substrates of β-carotene-15,15′-dioxygenase (BCO1), a cytosolic enzyme that catalyzes their centric oxidative cleavage to release retinaldehyde (retinal), from which all other natural vitamin A retinoids can be produced [5]. The vitamin A retinoids are essential nutrients required for vision (retinaldehyde) and gene expression control relevant to many developmental and physiological processes (mainly retinoic acid). Retinoids can be obtained independent of carotenoids through the intake of preformed vitamin A found in foods of animal origin. In industrialized countries, for instance, it has been estimated that preformed vitamin A accounts for nearly 65% of total human vitamin A intake, carotenoids make up 35% [6]. Ultimately, however, all natural retinoid present in mammals is derived from provitamin A carotenoids, either directly or indirectly through an animal lower in the food chain [7], and retinoids are thus considered a class of apocarotenoids [8]. Mammals express a second carotenoid cleavage enzyme, β-carotene-9′,10′-oxygenase (BCO2), which is a mitochondrial enzyme with a broader substrate specificity that cleaves eccentrically both provitamin A carotenoids and other carotenoids, such as cis lycopene, and the xanthophylls lutein and zeaxanthin, yielding apo-10′-carotenoids. Cumulative evidence indicates that, besides the retinoids, nonretinoid apocarotenoids may also impact cellular functions and influence mammalian health [8].

Adiposity reducing activity has been demonstrated both for provitamin A carotenoids and non-provitamin A carotenoids in animal studies (reviewed in [[9], [10], [11]]). The antiobesity activity of β-carotene in rodents is related to its provitamin A activity [12], in line with proven antiadiposity activities of retinoids (to which we shall refer in more detail later). Nevertheless, carotenoids per se, nonretinoid apocarotenoids, and carotenoid conversion products other than apocarotenoids may also have biological activities of interest in the context of body fat control and metabolic health. In this review, we use the term “carotenoid conversion products” (CCPs) to collectively refer to retinoid and nonretinoid apocarotenoids, as well as other type of natural carotenoid derived metabolites. It should be emphasized that, for most cell model-based and in vivo experimental studies, it remains unknown if it is the parent supplemented compound, a metabolic derivative(s) or both which is/are responsible for observed effects. A simplified overview of the relationships among carotenoids and their metabolites including retinoids is shown in Fig. 1.

Most studies dealing with the antiobesity activity of carotenoids have used rodents as animal models. This is explained because well-established rodent models of genetic and dietary obesity are available and because molecular physiology of body fat control has been most studied in rodents and resembles that in humans. Rodents are omnivorous animals, and laboratory rodent chows do contain carotenoids, coming for instance from dehydrated alfalfa meal [13], whereas the concentration of carotenoids in defined (purified) experimental diets is presumably lower than that in chows. Importantly, oxidative cleavage of carotenoids such as provitamin A carotenoids and lutein is more active in rodents than in humans. Consequently, rodents do not accumulate these carotenoids in plasma and tissues when fed at reasonable, “physiological doses”, whereas humans do accumulate them. The difference has been related to the catalytic properties of the carotenoid cleavage enzymes; for instance, murine BCO2 is more active on lutein in vitro than the human (or the macaque) enzyme [14,15]. Because of this, wild-type rodents are generally considered more suitable models to examine the biological properties of carotenoid cleavage products than of intact carotenoids. However, the scenario may not be equal for all carotenoids. For instance, rodents accumulate lycopene in tissues even when supplemented at low doses (e.g. 0.001% in the diet) and might be a good model to study biological actions of lycopene [16,17].

The antiobesity activity of carotenoids and CCPs has been linked to effects in multiple tissues, which are most likely interrelated effects, as there is extensive cross-talk among tissues in mammals through metabolism and neuroendocrine signaling. Nevertheless, important targets in the antiobesity action of carotenoids and CCPs are the adipose tissues, both white adipose tissue (WAT) and brown adipose tissue (BAT). This is not surprising, considering that adipose tissues play critical physiological and pathological roles in lipid and energy metabolism and obesity, and, at the same time, are relevant sites of carotenoid and retinoid storage and metabolism in mammals [9,11].

This work narratively reviews the connections of carotenoids and CCPs with adipose tissue biology and obesity as revealed by cell and animal intervention studies, studies addressing the role of endogenous retinoid metabolism, and human studies. First, key aspects of adipose tissue biology and of carotenoid and retinoid metabolism in it are introduced (Section 2). Animal studies demonstrating antiadiposiy activity of carotenoids and CCPs are then introduced (Section 3), followed by a compilation of general mechanisms that may be behind this activity and related health end-points (Section 4). The antiadiposity action of carotenoids and CCPs introduced in Section 3 is dissected in Section 5, by reviewing their reported impact on different aspects of WAT and BAT biology, including mechanistic clues when available. Section 6 focuses on reported effects of carotenoids and CCPs on non-adipose tissues that may indirectly affect adipose tissue metabolism and obesity. Human epidemiological and intervention studies relating carotenoids and their derivatives to the control of body fat content are reviewed in Section 7. In Section 8, we consider human genetic variability influencing carotenoid and vitamin A metabolism, particularly in adipose tissue, as a potentially relevant aspect towards personalization of dietary recommendations to prevent or manage obesity and optimize metabolic health. Finally, Section 9 summarizes main findings and highlights aspects for future research.

Section snippets

Overview of adipose tissues functions

WAT is specialized in the storage as triglycerides of excess ingested energy (over the energy needed to meet ongoing expenses), and in the regulated supply of energy to other tissues when needed, in the form of fatty acids resulting from lipolysis of stored triglycerides. WAT expansion occurs both by hyperplasia (increased number) of adipocytes, which implies the proliferation of progenitor cells contained in the adipose depots and the differentiation of the resulting cell progeny into

Carotenoids and carotenoid derivatives with antiadiposity activity in animal intervention studies

Antiadiposity activity has been reported for provitamin A carotenoids, in particular β-carotene [12] and β-cryptoxanthin [43], and certain non-provitamin A carotenoids such as: zeaxanthin [44], lycopene [[45], [46], [47]], the green algal carotenoid siphonaxanthin [48], the marine carotenoids fucoxanthin (reviewed in [49]) and astaxanthin [50,51], and the saffron carotenoids crocetin [52] and crocin [53]. Studies reviewed involving supplementation in post-weaned animals are summarized in Table 1

General mechanisms of carotenoids and carotenoids derivatives action

Mechanisms behind antiobesity, anti-inflammatory and antioxidant effects of carotenoids and CCPs might be multiple, as extensively reviewed elsewhere [3,9,30,72,73], and will only be briefly summarized here (Fig. 2).

First, carotenoids, retinoids and other CCPs can impact gene expression and cell function by acting as direct interacting ligands of transcription factors of the nuclear receptor superfamily, among them notably the canonical retinoic acid receptors (RARs), the retinoid X receptors

White adipogenesis

Adipogenesis refers to the formation of new adipocytes from precursor cells. The process has been studied in depth in clonal white preadipocyte cell lines, such as mouse 3T3-L1 cells, and it can be recapitulated in primary cultures established from the stromal/vascular fraction isolated from fat depots (which contains preadipocytes and perivascular adipocyte progenitor cells), or mouse embryonic fibroblasts (MEFs), among other models. Adipogenesis takes place in vivo throughout life, to account

Activities of carotenoids and carotenoid derivatives in non-adipose tissues may affect adipose tissue metabolism and obesity

By modulating nutrient partitioning and the secretion of adipokines, the activity of carotenoids and CCPs (notably vitamin A retinoids) in adipose tissues may elicit adipose-driven protective effects against obesity and the metabolic syndrome involving other key metabolic tissues, such as skeletal muscle, the liver or the brain. Moreover, as further reviewed in this section, dietary carotenoids and retinoids reach those organs directly, where they also regulate metabolic pathways and the

Human epidemiological and intervention studies linking carotenoids and carotenoid derivatives to the control of body adiposity

Evidence of a relationship of carotenoids with human obesity and related health parameters comes mainly from epidemiological studies. Many studies have reported lower serum carotenoids in overweight and obese children, adolescents and adults, and an inverse association between carotenoids concentrations in blood and measures of obesity, such as BMI or waist circumference, in some cases even after adjusting for potential confounders such as the intake of fruit and vegetables, fat or fiber, among

Relevance of genetic variants to carotenoid and vitamin A metabolism in adipose tissue in humans

Genetic variation in or near genes involved in carotenoid uptake, transport and metabolism has been shown to be associated in humans with circulating carotenoids levels, both basal and after a test meal ingestion [262,263]. Genetic variation in some of these same genes and additional ones influences as well vitamin A status and vitamin A bioavailability [264]. Most of the literature on this topic focuses on carotenoid intestinal absorption and management in the enterocytes. However, it is

Final considerations and future research

A connection of carotenoids and carotenoids derivatives with the energy homeostasis system of mammals is well established. This connection implicates the natural vitamin A retinoids (which ultimately all come from carotenoids), but extends beyond the latter to include as well non-provitamin A carotenoids, nonretinoid apocarotenoids, and certain nonapocarotenoid derivatives. For these different but related types of compounds, metabolic health promoting activities usually linked to an

Credit author statement

All authors contributed to different parts of the work.

Declaration of competing interest

Authors have no interest to declare.

Acknowledgements

The authors acknowledge funding support from the Spanish Government (grant PGC2018-097436-B-I00; Agencia Estatal de Investigación, MICIU/FEDER, EU). The group is a member of the European COST-Action EUROCAROTEN (CA15136; EU Framework Programme Horizon 2020), and the Spanish Network of Excellence CaRed (grant BIO2017-90877-REDT; Agencia Estatal de Investigación, MICIU/FEDER, EU). CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn) is an initiative of the ISCIII (Spanish Government).

References (288)

  • R. Schreiber et al.

    Retinyl ester hydrolases and their roles in vitamin A homeostasis

    Biochim. Biophys. Acta

    (2012)
  • E. Gouranton et al.

    Purified low-density lipoprotein and bovine serum albumin efficiency to internalise lycopene into adipocytes

    Food Chem. Toxicol.

    (2008)
  • W.S. Blaner

    Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders

    Pharmacol. Ther.

    (2019)
  • S. Hessel et al.

    CMO1 deficiency abolishes vitamin A production from beta-carotene and alters lipid metabolism in mice

    J. Biol. Chem.

    (2007)
  • M.A. Kane et al.

    HPLC/UV quantitation of retinal, retinol, and retinyl esters in serum and tissues

    Anal. Biochem.

    (2008)
  • A. El-Sohemy et al.

    Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake

    Am. J. Clin. Nutr.

    (2002)
  • H.Y. Chung et al.

    Site-specific concentrations of carotenoids in adipose tissue: relations with dietary and serum carotenoid concentrations in healthy adults

    Am. J. Clin. Nutr.

    (2009)
  • A. Harari et al.

    Obesity and insulin resistance are inversely associated with serum and adipose tissue carotenoid concentrations in adults

    J. Nutr.

    (2020)
  • J. Wang et al.

    Lycopene supplementation attenuates western diet-induced body weight gain through increasing the expressions of thermogenic/mitochondrial functional genes and improving insulin resistance in the adipose tissue of obese mice

    J. Nutr. Biochem.

    (2019)
  • Z.S. Li et al.

    The green algal carotenoid siphonaxanthin inhibits adipogenesis in 3T3-L1 preadipocytes and the accumulation of lipids in white adipose tissue of KK-Ay mice

    J. Nutr.

    (2015)
  • H. Maeda et al.

    Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues

    Biochem. Biophys. Res. Commun.

    (2005)
  • M.L. Bonet et al.

    Lipid metabolism in mammalian tissues and its control by retinoic acid

    Biochim. Biophys. Acta

    (2012)
  • B.C. Ip et al.

    Lycopene and apo-10′-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in beta-carotene-9′,10′-oxygenase knockout male mice

    J. Nutr.

    (2015)
  • A. Kaulmann et al.

    Carotenoids, inflammation, and oxidative stress--implications of cellular signaling pathways and relation to chronic disease prevention

    Nutr. Res.

    (2014)
  • N. Shaw et al.

    Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta

    J. Biol. Chem.

    (2003)
  • E. Gouranton et al.

    Apo-10′-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors

    Biochim. Biophys. Acta

    (2011)
  • M. Inoue et al.

    Astaxanthin functions differently as a selective peroxisome proliferator-activated receptor gamma modulator in adipocytes and macrophages

    Biochem. Pharmacol.

    (2012)
  • K. Linnewiel-Hermoni et al.

    Carotenoid derivatives inhibit nuclear factor kappa B activity in bone and cancer cells by targeting key thiol groups

    Free Radic. Biol. Med.

    (2014)
  • K. Linnewiel et al.

    Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system

    Free Radic. Biol. Med.

    (2009)
  • Y.M. Lee et al.

    Retinoic acid leads to cytoskeletal rearrangement through AMPK-Rac1 and stimulates glucose uptake through AMPK-p38 MAPK in skeletal muscle cells

    J. Biol. Chem.

    (2008)
  • Y.H. Chang et al.

    Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathway

    Biochem. Biophys. Res. Commun.

    (2018)
  • S.R. Farmer

    Transcriptional control of adipocyte formation

    Cell Metab.

    (2006)
  • P. Arner et al.

    Fat cell turnover in humans

    Biochem. Biophys. Res. Commun.

    (2010)
  • S. Virtue et al.

    Adipose tissue expandability, lipotoxicity and the metabolic syndrome—an allostatic perspective

    Biochim. Biophys. Acta

    (2010)
  • WHO

    Obesity and Overweight. Fact sheet N°3112015

    (2017)
  • D. Weber et al.

    The contribution of beta-carotene to vitamin a supply of humans

    Mol. Nutr. Food Res.

    (2012)
  • E.H. Harrison et al.

    Apocarotenoids: emerging roles in mammals

    Annu. Rev. Nutr.

    (2018)
  • M.L. Bonet et al.

    Carotenoids and their conversion products in the control of adipocyte function, adiposity and obesity

    Arch. Biochem. Biophys.

    (2015)
  • J. Coronel et al.

    Beta-carotene in obesity research: technical considerations and current status of the field

    Nutrients

    (2019)
  • L. Mounien et al.

    Anti-obesity effect of carotenoids: direct impact on adipose tissue and adipose tissue-driven indirect effects

    Nutrients

    (2019)
  • J. Amengual et al.

    Beta-carotene reduces body adiposity of mice via BCMO1

    PLoS One

    (2011)
  • S.A. Lee et al.

    Cardiac dysfunction in beta-carotene-15,15′-dioxygenase-deficient mice is associated with altered retinoid and lipid metabolism

    Am. J. Physiol. Heart Circ. Physiol.

    (2014)
  • B. Li et al.

    Inactivity of human beta,beta-carotene-9′,10′-dioxygenase (BCO2) underlies retinal accumulation of the human macular carotenoid pigment

    Proc. Natl. Acad. Sci. U. S. A.

    (2014)
  • S. Agarwal et al.

    Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study

    Lipids

    (1998)
  • T.W. Boileau et al.

    Bioavailability of all-trans and cis-isomers of lycopene

    Exp. Biol. Med.

    (2002)
  • N. Ouchi et al.

    Adipokines in inflammation and metabolic disease

    Nat Rev Immunol

    (2011)
  • F. Villarroya et al.

    Brown adipose tissue as a secretory organ

    Nat Rev Endocrinol

    (2017)
  • G. Maurizi et al.

    Adipocytes properties and crosstalk with immune system in obesity-related inflammation

    J. Cell. Physiol.

    (2018)
  • M.A.K. Widjaja-Adhi et al.

    The molecular aspects of absorption and metabolism of carotenoids and retinoids in vertebrates

    Biochimica et biophysica acta. Molecular and cell biology of lipids

    (2019)
  • L.A. Kaplan et al.

    Carotenoid composition, concentrations, and relationships in various human organs

    Clin Physiol Biochem

    (1990)
  • Cited by (46)

    • Algae biotechnology for industrial wastewater treatment, bioenergy production, and high-value bioproducts

      2022, Science of the Total Environment
      Citation Excerpt :

      Carotenoids have been shown to reduce oxidative stress, which benefits cardiovascular health. In addition, they can help prevent obesity, diabetes, some cancers, and neurological complications (Bonet et al., 2020; Eggersdorfer and Wyss, 2018; Rowles III and Erdman Jr, 2020). Where chronic diseases are significantly associated with an increase in oxidative stress.

    • Microalgae carotenoids: An overview of biomedical applications

      2022, Algal Biotechnology: Integrated Algal Engineering for Bioenergy, Bioremediation, and Biomedical Applications
    View all citing articles on Scopus

    This article is part of a Special Issue entitled Carotenoids recent advances in cell and molecular biology edited by Johannes von Lintig and Loredana Quadro.

    View full text